Antiviral therapy, vol 22, iss 3 Rockstroh, JK; Plonski, F; Bansal, M; Fätkenheuer, G; Small, CB; Asmuth, DM; et al.(2017). Hepatic safety of maraviroc in patients with HIV-1 and hepatitis C and/or B virus: 144-week results from a randomized, placebo-controlled trial. Antiviral Therapy, 22(3), 263-269. doi: 10.3851/IMP3116. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/68s6t2xj